AprilBio Co Ltd (397030)

Currency in KRW
51,800
+300(+0.58%)
Closed·
397030 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
51,30055,600
52 wk Range
16,16076,700
Key Statistics
Bid/Ask
51,700.00 / 51,800.00
Prev. Close
51,500
Open
54,000
Day's Range
51,300-55,600
52 wk Range
16,160-76,700
Volume
241.96K
Average Volume (3m)
304.73K
1-Year Change
204.7059%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
397030 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
100,000
Upside
+93.05%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 100,000
(+93.05% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
01-03-2026
EPS / Forecast
-98.17 / 67.00
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

397030 Income Statement

Compare 397030 to Peers and Sector

Metrics to compare
397030
Peers
Sector
Relationship
P/E Ratio
−131.7x−16.4x−0.5x
PEG Ratio
0.86−0.250.00
Price/Book
13.3x3.2x2.6x
Price / LTM Sales
590.0x20.5x3.1x
Upside (Analyst Target)
90.8%94.5%54.0%
Fair Value Upside
Unlock15.2%6.5%Unlock

AprilBio Co.,Ltd. develops long-acting type biobetter and antibody biologics. The company develops antibody drugs, double antibodies, long-acting antibody drugs, long-acting protein drugs, and ADC-applied antibodies. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
998.39K4.28%51.42B
Other Institutional Investors
3.99M17.08%205.36B
Public Companies & Retail Investors
18.36M78.64%945.37B
Total
23.34M100.00%1.2T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Sm-Sino Technology Investment Co., Ltd.4.66%10,87,4105,60,01,615
JPMorgan Chase & Co.4.64%10,83,6125,58,06,018

FAQ

What Is the AprilBio (397030) Share Price Today?

The AprilBio share price today is 51,800.

What is the current AprilBio (397030) share price and day range?

As of 21-05-2026, the AprilBio share price is 51,800, with a previous close of 51,500. The share price has ranged from 51,300 to 55,600 today, while the 52-week range spans from 16,160 to 76,700.

What Is the AprilBio Market Cap?

As of today, AprilBio market cap is 1.2T.

What Is the AprilBio (397030) Share Price Target?

The average 12-month share price target for AprilBio is 1,00,000, with a high estimate of 100000 and a low estimate of 100000. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +93.05% Upside potential.

What Is AprilBio's Earnings Per Share (TTM)?

The AprilBio EPS (TTM) is -429.

From a Technical Analysis Perspective, Is 397030 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does AprilBio Trade On?

AprilBio is listed and trades on the KOSDAQ.

What Is the Stock Symbol for AprilBio?

The stock symbol for AprilBio is "397030."

How Many Times Has AprilBio Stock Split?

AprilBio has split 1 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.